Biotech grants in Poland
Explore Biotech grants for companies in Poland. This list brings together funding for drug discovery, diagnostics, cell and gene therapy, biomanufacturing and life-science research from Polish innovation agencies, research funders and foundations, EU and international programs open to applicants in Poland, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Biotech in Poland come first.
Showing 1-24 of 632 grants
MAESTRO 18
🇵🇱NCN · Poland
Funds advanced Polish research groups with ambitious scientific goals in frontier topics.
SONATA BIS 16
🇵🇱NCN · Poland
Funds established Polish researchers for team-based basic science projects connecting lab discovery to excellence.
FENG Smart Path — Consortium Projects
🇵🇱NCBR · Poland
Supports consortiums linking Polish enterprises with research teams to turn laboratory results into market products.
WEAVE-UNISONO
🇵🇱NCN · Poland
Funds bilateral and trilateral Polish research collaborations through lead-agency international partnerships.
Launch Platforms for New Ideas (Platformy startowe dla nowych pomysłów)
🇵🇱PARP · Poland
Supports idea-stage entrepreneurs establishing innovative companies in Eastern Poland regions.
NCBR International JTC
🇵🇱NCBR · Poland
Connects Polish organizations to international joint technology collaborations through NCBR International JTC, enabling shared global project teams.
SONATA 22
🇵🇱NCN · Poland
Supports early-career Polish researchers through fundamental science grants with team-scale opportunities.
Ścieżka SMART — SME R&D Projects (Q4
🇵🇱PARP · Poland
Supports another Polish intake for small and medium enterprises pursuing innovation research.
Grants for Eurogrants — Call IV (Granty na Eurogranty — Nabór IV)
🇵🇱PARP · Poland
Provides reimbursement for Polish organizations preparing major European funding applications.
Grants for Eurogrants — Call V (Granty na Eurogranty — Nabór V)
🇵🇱PARP · Poland
Provides reimbursement for Polish organizations preparing major European funding applications.
PRELUDIUM 25
🇵🇱NCN · Poland
Supports early-career researchers before doctoral completion to run independent basic research projects in any discipline.
SMART Path — Implementation of R&D Results (Ścieżka SMART)
🇵🇱PARP · Poland
Supports Polish small and medium enterprises through Ścieżka SMART implementation to convert outcomes into practical uses.
Startup Booster Poland — Smart UP
🇵🇱PARP · Poland
Funds early-stage Polish startups through accredited accelerator operators and startup support.
MINIATURA 10
🇵🇱NCN · Poland
Funds compact Polish projects for single scientific actions, pilot experiments, or research mobility.
OPUS 31
🇵🇱NCN · Poland
Funds fundamental research in Poland through competitive grants for broad research communities and university teams.
STEP Path A: Biotechnology
🇵🇱NCBR · Poland
Grants Polish biotech companies and consortia up to PLN 140 million for critical-tech R&D.
Eurostars Call 11
🇪🇺EUREKA · Global / Multinational
Funds small and medium enterprises across Europe via Eurostars Call 11 for collaborative innovation with international partners.
Euratom Radiation Protection Partnership (PIANOFORTE)
🇪🇺European Commission · European Union
Funds PIANOFORTE’s 2026-27 continuation, an EU radiation-safety research partnership — only for its current members and any partner who joins them.
Horizon Cancer Mission: Microbiome Early Detection
🇪🇺European Commission · European Union
Funds a €15M project that turns microbiome signals into a test for spotting cancer risk years ahead of any symptoms.
Horizon Cancer Mission: Ukraine Research Capacity
🇪🇺European Commission · European Union
Funds a €5M programme that pairs EU and Associated Country research institutions with Ukrainian cancer centres for joint training and staff exchanges.
Horizon Cancer Mission: Virtual Human Twins
🇪🇺European Commission · European Union
Funds up to four €8-9M grants for teams building AI-driven digital models of a patient's cancer to predict how it develops and guide personalised treatment.
Horizon Cancer: Pragmatic Immunotherapy Trials
🇪🇺European Commission · European Union
Funds three pragmatic clinical trials, €7-8M each, testing existing cancer immunotherapies in real-world care for patients whose disease resists treatment.
Horizon Health: Rare Disease Partnership (ERDERA) Phase 2
🇪🇺European Commission · European Union
Funds rare-disease research calls, clinical trial networks and shared data for ERDERA's second phase — open only to the existing coordinator.
EIC Transition Open
🇪🇺EIC · European Union
Supports European deep-tech ventures advancing laboratory research toward validated prototypes and near-market technologies.